Histone lysine demethylases and their functions in cancer
Histone lysine demethylases (KDMs) are enzymes that remove the methylation marks on lysines in nucleosomes' histone tails. These changes in methylation marks regulate gene transcription during both development and malignant transformation. Depending on which lysine residue is targeted, the effe...
Gespeichert in:
| Veröffentlicht in: | International journal of cancer 2021-05, Vol.148 (10), p.2375-2388 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 2388 |
|---|---|
| container_issue | 10 |
| container_start_page | 2375 |
| container_title | International journal of cancer |
| container_volume | 148 |
| creator | Sterling, Jayden Menezes, Sharleen V. Abbassi, Ramzi H. Munoz, Lenka |
| description | Histone lysine demethylases (KDMs) are enzymes that remove the methylation marks on lysines in nucleosomes' histone tails. These changes in methylation marks regulate gene transcription during both development and malignant transformation. Depending on which lysine residue is targeted, the effect of a given KDM on gene transcription can be either activating or repressing, and KDMs can regulate the expression of both oncogenes and tumour suppressors. Thus, the functions of KDMs can be regarded as both oncogenic and tumour suppressive, contingent on cell context and the enzyme isoform. Finally, KDMs also demethylate nonhistone proteins and have a variety of demethylase‐independent functions. These epigenetic and other mechanisms that KDMs control make them important regulators of malignant tumours. Here, we present an overview of eight KDM subfamilies, their most‐studied lysine targets and selected recent data on their roles in cancer stem cells, tumour aggressiveness and drug tolerance. |
| doi_str_mv | 10.1002/ijc.33375 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2456415494</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2509258190</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3885-a9b25aa343ad7bb3725971a8ca3c9b186f58d0cc460fa0c71416bda0d7005db3</originalsourceid><addsrcrecordid>eNp1kE9LwzAYh4Mobk4PfgEpeNFDtzdJ0zRHGf6ZDLzsHtIkZRltOpMW2be32ulB8PQ7vA8PLw9C1xjmGIAs3E7PKaWcnaApBsFTIJidoulwg5Rjmk_QRYw7AIwZZOdoQikmBediisSLi13rbVIfohvG2MZ220Otoo2J8ibpttaFpOq97lzrY-J8opXXNlyis0rV0V4dd4Y2T4-b5Uu6fnteLR_WqaZFwVIlSsKUohlVhpcl5YQJjlWhFdWixEVescKA1lkOlQLNcYbz0igwHICZks7Q3ajdh_a9t7GTjYva1rXytu2jJBnLM8wykQ3o7R901_bBD89JwkAQVmABA3U_Ujq0MQZbyX1wjQoHiUF-5ZRDTvmdc2Bvjsa-bKz5JX_6DcBiBD5cbQ__m-TqdTkqPwGgdH0j</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2509258190</pqid></control><display><type>article</type><title>Histone lysine demethylases and their functions in cancer</title><source>Wiley Online Library Journals Frontfile Complete</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Sterling, Jayden ; Menezes, Sharleen V. ; Abbassi, Ramzi H. ; Munoz, Lenka</creator><creatorcontrib>Sterling, Jayden ; Menezes, Sharleen V. ; Abbassi, Ramzi H. ; Munoz, Lenka</creatorcontrib><description>Histone lysine demethylases (KDMs) are enzymes that remove the methylation marks on lysines in nucleosomes' histone tails. These changes in methylation marks regulate gene transcription during both development and malignant transformation. Depending on which lysine residue is targeted, the effect of a given KDM on gene transcription can be either activating or repressing, and KDMs can regulate the expression of both oncogenes and tumour suppressors. Thus, the functions of KDMs can be regarded as both oncogenic and tumour suppressive, contingent on cell context and the enzyme isoform. Finally, KDMs also demethylate nonhistone proteins and have a variety of demethylase‐independent functions. These epigenetic and other mechanisms that KDMs control make them important regulators of malignant tumours. Here, we present an overview of eight KDM subfamilies, their most‐studied lysine targets and selected recent data on their roles in cancer stem cells, tumour aggressiveness and drug tolerance.</description><identifier>ISSN: 0020-7136</identifier><identifier>EISSN: 1097-0215</identifier><identifier>DOI: 10.1002/ijc.33375</identifier><identifier>PMID: 33128779</identifier><language>eng</language><publisher>Hoboken, USA: John Wiley & Sons, Inc</publisher><subject>Cancer ; DNA methylation ; drug resistance ; Drug tolerance ; Epigenetics ; histone lysine demethylase ; histone methylation ; Histones ; Lysine ; Medical research ; Nonhistone proteins ; Nucleosomes ; Stem cells ; Tumors</subject><ispartof>International journal of cancer, 2021-05, Vol.148 (10), p.2375-2388</ispartof><rights>2020 Union for International Cancer Control</rights><rights>2020 Union for International Cancer Control.</rights><rights>2021 UICC</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3885-a9b25aa343ad7bb3725971a8ca3c9b186f58d0cc460fa0c71416bda0d7005db3</citedby><cites>FETCH-LOGICAL-c3885-a9b25aa343ad7bb3725971a8ca3c9b186f58d0cc460fa0c71416bda0d7005db3</cites><orcidid>0000-0002-7625-5646</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fijc.33375$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fijc.33375$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,777,781,1412,27905,27906,45555,45556</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33128779$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sterling, Jayden</creatorcontrib><creatorcontrib>Menezes, Sharleen V.</creatorcontrib><creatorcontrib>Abbassi, Ramzi H.</creatorcontrib><creatorcontrib>Munoz, Lenka</creatorcontrib><title>Histone lysine demethylases and their functions in cancer</title><title>International journal of cancer</title><addtitle>Int J Cancer</addtitle><description>Histone lysine demethylases (KDMs) are enzymes that remove the methylation marks on lysines in nucleosomes' histone tails. These changes in methylation marks regulate gene transcription during both development and malignant transformation. Depending on which lysine residue is targeted, the effect of a given KDM on gene transcription can be either activating or repressing, and KDMs can regulate the expression of both oncogenes and tumour suppressors. Thus, the functions of KDMs can be regarded as both oncogenic and tumour suppressive, contingent on cell context and the enzyme isoform. Finally, KDMs also demethylate nonhistone proteins and have a variety of demethylase‐independent functions. These epigenetic and other mechanisms that KDMs control make them important regulators of malignant tumours. Here, we present an overview of eight KDM subfamilies, their most‐studied lysine targets and selected recent data on their roles in cancer stem cells, tumour aggressiveness and drug tolerance.</description><subject>Cancer</subject><subject>DNA methylation</subject><subject>drug resistance</subject><subject>Drug tolerance</subject><subject>Epigenetics</subject><subject>histone lysine demethylase</subject><subject>histone methylation</subject><subject>Histones</subject><subject>Lysine</subject><subject>Medical research</subject><subject>Nonhistone proteins</subject><subject>Nucleosomes</subject><subject>Stem cells</subject><subject>Tumors</subject><issn>0020-7136</issn><issn>1097-0215</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNp1kE9LwzAYh4Mobk4PfgEpeNFDtzdJ0zRHGf6ZDLzsHtIkZRltOpMW2be32ulB8PQ7vA8PLw9C1xjmGIAs3E7PKaWcnaApBsFTIJidoulwg5Rjmk_QRYw7AIwZZOdoQikmBediisSLi13rbVIfohvG2MZ220Otoo2J8ibpttaFpOq97lzrY-J8opXXNlyis0rV0V4dd4Y2T4-b5Uu6fnteLR_WqaZFwVIlSsKUohlVhpcl5YQJjlWhFdWixEVescKA1lkOlQLNcYbz0igwHICZks7Q3ajdh_a9t7GTjYva1rXytu2jJBnLM8wykQ3o7R901_bBD89JwkAQVmABA3U_Ujq0MQZbyX1wjQoHiUF-5ZRDTvmdc2Bvjsa-bKz5JX_6DcBiBD5cbQ__m-TqdTkqPwGgdH0j</recordid><startdate>20210515</startdate><enddate>20210515</enddate><creator>Sterling, Jayden</creator><creator>Menezes, Sharleen V.</creator><creator>Abbassi, Ramzi H.</creator><creator>Munoz, Lenka</creator><general>John Wiley & Sons, Inc</general><general>Wiley Subscription Services, Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7TO</scope><scope>7U9</scope><scope>H94</scope><scope>K9.</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-7625-5646</orcidid></search><sort><creationdate>20210515</creationdate><title>Histone lysine demethylases and their functions in cancer</title><author>Sterling, Jayden ; Menezes, Sharleen V. ; Abbassi, Ramzi H. ; Munoz, Lenka</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3885-a9b25aa343ad7bb3725971a8ca3c9b186f58d0cc460fa0c71416bda0d7005db3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Cancer</topic><topic>DNA methylation</topic><topic>drug resistance</topic><topic>Drug tolerance</topic><topic>Epigenetics</topic><topic>histone lysine demethylase</topic><topic>histone methylation</topic><topic>Histones</topic><topic>Lysine</topic><topic>Medical research</topic><topic>Nonhistone proteins</topic><topic>Nucleosomes</topic><topic>Stem cells</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sterling, Jayden</creatorcontrib><creatorcontrib>Menezes, Sharleen V.</creatorcontrib><creatorcontrib>Abbassi, Ramzi H.</creatorcontrib><creatorcontrib>Munoz, Lenka</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sterling, Jayden</au><au>Menezes, Sharleen V.</au><au>Abbassi, Ramzi H.</au><au>Munoz, Lenka</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Histone lysine demethylases and their functions in cancer</atitle><jtitle>International journal of cancer</jtitle><addtitle>Int J Cancer</addtitle><date>2021-05-15</date><risdate>2021</risdate><volume>148</volume><issue>10</issue><spage>2375</spage><epage>2388</epage><pages>2375-2388</pages><issn>0020-7136</issn><eissn>1097-0215</eissn><abstract>Histone lysine demethylases (KDMs) are enzymes that remove the methylation marks on lysines in nucleosomes' histone tails. These changes in methylation marks regulate gene transcription during both development and malignant transformation. Depending on which lysine residue is targeted, the effect of a given KDM on gene transcription can be either activating or repressing, and KDMs can regulate the expression of both oncogenes and tumour suppressors. Thus, the functions of KDMs can be regarded as both oncogenic and tumour suppressive, contingent on cell context and the enzyme isoform. Finally, KDMs also demethylate nonhistone proteins and have a variety of demethylase‐independent functions. These epigenetic and other mechanisms that KDMs control make them important regulators of malignant tumours. Here, we present an overview of eight KDM subfamilies, their most‐studied lysine targets and selected recent data on their roles in cancer stem cells, tumour aggressiveness and drug tolerance.</abstract><cop>Hoboken, USA</cop><pub>John Wiley & Sons, Inc</pub><pmid>33128779</pmid><doi>10.1002/ijc.33375</doi><tpages>14</tpages><orcidid>https://orcid.org/0000-0002-7625-5646</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0020-7136 |
| ispartof | International journal of cancer, 2021-05, Vol.148 (10), p.2375-2388 |
| issn | 0020-7136 1097-0215 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2456415494 |
| source | Wiley Online Library Journals Frontfile Complete; EZB-FREE-00999 freely available EZB journals |
| subjects | Cancer DNA methylation drug resistance Drug tolerance Epigenetics histone lysine demethylase histone methylation Histones Lysine Medical research Nonhistone proteins Nucleosomes Stem cells Tumors |
| title | Histone lysine demethylases and their functions in cancer |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T21%3A12%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Histone%20lysine%20demethylases%20and%20their%20functions%20in%20cancer&rft.jtitle=International%20journal%20of%20cancer&rft.au=Sterling,%20Jayden&rft.date=2021-05-15&rft.volume=148&rft.issue=10&rft.spage=2375&rft.epage=2388&rft.pages=2375-2388&rft.issn=0020-7136&rft.eissn=1097-0215&rft_id=info:doi/10.1002/ijc.33375&rft_dat=%3Cproquest_cross%3E2509258190%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2509258190&rft_id=info:pmid/33128779&rfr_iscdi=true |